Prestige Brands Holdings Inc (PBH.N)

PBH.N on New York Stock Exchange

32.39USD
4:06pm EDT
Price Change (% chg)

$-0.13 (-0.40%)
Prev Close
$32.52
Open
$32.60
Day's High
$32.76
Day's Low
$32.39
Volume
63,584
Avg. Vol
72,137
52-wk High
$36.64
52-wk Low
$25.00

PBH.N

Chart for PBH.N

About

Prestige Brands Holdings, Inc. (Prestige) is a holding company. The Company, along with its subsidiaries, is engaged in the marketing, sales and distribution of over-the-counter (OTC) Healthcare and Household Cleaning brands to mass merchandisers, drug stores, supermarkets, club and dollar stores primarily in the United States... (more)

Overall

Beta: 2.01
Market Cap (Mil.): $1,690.09
Shares Outstanding (Mil.): 51.97
Dividend: --
Yield (%): --

Financials

  PBH.N Industry Sector
P/E (TTM): 24.83 18.37 34.35
EPS (TTM): 1.31 -- --
ROI: 4.00 9.58 50.14
ROE: 12.65 10.98 58.53
Search Stocks

Prestige Brands gets U.S. antitrust approval to buy Insight with divestiture

WASHINGTON - Prestige Brands Holdings Inc , which markets and distributes healthcare and cleaning products, has won U.S. antitrust approval to buy Insight Pharmaceuticals Corp on condition that it divest a motion-sickness drug, the Federal Trade Commission said on Thursday.

28 Aug 2014

Prestige Brands gets U.S. antitrust approval to buy Insight with divestiture

WASHINGTON, Aug 28 - Prestige Brands Holdings Inc , which markets and distributes healthcare and cleaning products, has won U.S. antitrust approval to buy Insight Pharmaceuticals Corp on condition that it divest a motion-sickness drug, the Federal Trade Commission said on Thursday.

28 Aug 2014

Prestige Brands boosts feminine care line with Insight Pharma buy

- Prestige Brands Holdings Inc , a marketer and distributor of healthcare and cleaning products, said it would buy Insight Pharmaceuticals Corp and seek further acquisitions to expand its range of feminine care products.

25 Apr 2014

UPDATE 2-Prestige Brands boosts feminine care line with Insight Pharma buy

* Deal value of $750 mln includes tax attributes of $100 mln

25 Apr 2014

CORRECTED-UPDATE 1-Prestige Brands to buy Insight Pharmaceuticals for $750 mln

* Deal value includes tax attributes worth about $100 mln

25 Apr 2014

Prestige Brands to buy Insight Pharmaceuticals for $750 mln

April 25 - Prestige Brands Holdings Inc, a marketer and distributor of healthcare and cleaning products, said it would buy rival Insight Pharmaceuticals Corp for $750 million in cash to expand its feminine care products range.

25 Apr 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks